Related references
Note: Only part of the references are listed.Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy A Systematic Review and Meta-analysis
Sonali Paul et al.
ANNALS OF INTERNAL MEDICINE (2016)
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
Shigeru Kusumoto et al.
CLINICAL INFECTIOUS DISEASES (2015)
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
K. Rajender Reddy et al.
GASTROENTEROLOGY (2015)
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
Robert P. Perrillo et al.
GASTROENTEROLOGY (2015)
Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg?
Adrian M. Di Bisceglie et al.
HEPATOLOGY (2015)
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy
Haruhito Totani et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments
Robert P. Perrillo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis
L. Mozessohn et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy
Ji Yun Lee et al.
LIVER INTERNATIONAL (2015)
The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy
Shasha Lu et al.
LEUKEMIA & LYMPHOMA (2015)
High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia
Chien-Yuan Chen et al.
PLOS ONE (2015)
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
Kai-Lin Chen et al.
CHINESE JOURNAL OF CANCER (2015)
Chemotherapy-Induced Hepatitis B Reactivation in Lymphoma Patients With Resolved HBV Infection: A Prospective Study
Chiun Hsu et al.
HEPATOLOGY (2014)
Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
Wai-Kay Seto et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection
M. Takahata et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
Yi-Hsiang Huang et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis
Hua-Jie Dong et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Reactivation of Hepatitis B Virus in Patients With Undetectable HBsAg Undergoing Chemotherapy for Malignant Lymphoma or Multiple Myeloma
Takeshi Matsui et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Immunosuppression and HBV Reactivation
Daniel Shouval et al.
SEMINARS IN LIVER DISEASE (2013)
Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy
Sung-Nan Pei et al.
ANNALS OF HEMATOLOGY (2012)
Closing the Gap between Methodologists and End-Users: R as a Computational Back-End
Byron C. Wallace et al.
JOURNAL OF STATISTICAL SOFTWARE (2012)
Hepatitis B virus management to prevent reactivation after chemotherapy: a review
Jessica P. Hwang et al.
SUPPORTIVE CARE IN CANCER (2012)
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
Yu Xuan Koo et al.
ANNALS OF HEMATOLOGY (2011)
Reactivation of Hepatitis B Virus After Rituximab-Containing Treatment in Patients With CD20-Positive B-Cell Lymphoma
Kosei Matsue et al.
CANCER (2010)
Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/HBcAb-positive: a multicenter retrospective study
Dongmei Ji et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy
D. Francisci et al.
INFECTION (2010)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
Winnie Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells
Gerta Ruecker et al.
STATISTICS IN MEDICINE (2009)
HB Vaccination in the Prevention of Viral Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Previous HBV Infection
Masahiro Onozawa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy
Clara Targhetta et al.
HAEMATOLOGICA (2008)
A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints
Roger M. Harbord et al.
STATISTICS IN MEDICINE (2006)
Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy
Chee-Kin Hui et al.
GASTROENTEROLOGY (2006)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
